Pharmacist and physician insight of vancomycin therapeutic drug-monitoring changes
The updated vancomycin guideline for treatment of serious methicillin-resistant Staphylococcus aureus infections prompted institutions to convert from trough to area-under-the-curve monitoring. The physician perception of the transition, coupled with that of pharmacists, was measured by pre- and pos...
Saved in:
Main Authors: | Eric R. Gregory (Author), Lucy Stun (Author), Matt J. Mason (Author), Nicole M. Wilson (Author), Kassem A. Hammoud (Author) |
---|---|
Format: | Book |
Published: |
Cambridge University Press,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vancomycin Prescribing Practices and Therapeutic Drug Monitoring for Critically Ill Neonatal and Pediatric Patients: A Survey of Physicians and Pharmacists in Hong Kong
by: Twinny Cheuk Hin Chow, et al.
Published: (2020) -
Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model
by: Kashif Hussain, et al.
Published: (2021) -
Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
by: Nicole Bradley, et al.
Published: (2023) -
The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin-A Pilot Study
by: Paul Firman, et al.
Published: (2022) -
Therapeutic drug monitoring of vancomycin in an obese patient with renal insufficiency
by: Said Abuhasna, et al.
Published: (2011)